Condition: HCC - Hepatocellular Carcinoma · Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
This is a multi-center, retrospective observational study in patients with liver cancer (HCC) to assess the impact of sarcopenia (muscle loss) on the prognosis, duration, and tolerance of systemic treatment.
This description comes directly from the study's public registry record.
Dr. Maurizio Biselli Principal Investigator, MD · +39 051 2142928 · maurizio.biselli@unibo.it
Always discuss trial participation with your own doctor first.
| IRCCS AOUBO Policlinico di S.Orsola | Bologna, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06805552